CNBC: Venture capitalist wages war against Parkinson’s, searches for miracle after his own diagnosis

August, 2017—It’s been less than a year since Jonathan Silverstein, a venture capitalist at health-care fund OrbiMed, received the diagnosis that changed everything.

Glucocerebrosidase is shaking up the synucleinopathies, Siebert et. al.

Multi-center analysis of glucocerebrosidase mutations in Parkinson disease, Sidransky et. al.

The relationship between glucocerebrosidase mutations and Parkinson disease, Migdalska-Richards et. al.

Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies, Sardi et. al.